CordenPharma Colorado is leasing 5505 Central, a newly completed, purpose-built peptide development lab at Flatiron Park in Boulder (US). Photo credit: CordenPharma Photo ...
BioMed Realty, the largest private owner and operator of real estate for the life science, technology and innovation ...
US-based CordenPharma Colorado has leased a 64,000ft² space at BioMed Realty’s Flatiron Park’s 5505 Central, which marks ...
Corden Pharma Colorado Inc., a developer and manufacturer of peptide drug substances, has leased the 64,000-square-foot 5505 ...
Will house process development and analytical services for advanced peptide API production from development through commercialization.
BioMed Realty, the largest private owner and operator of real estate for the life science, technology and innovation industries, announced that CordenPharma Colorado, a leading peptide drug substance ...